What is JBIO's market capitalization?

JBIO (JBIO) reported market capitalization of $692.89M in Q1 2026.

What does market capitalization mean?

The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.

JBIO JBIO Market capitalization

Market capitalization at other companies

Vertex PharmaceuticalsVRTX

$113.44B-8.9%

Travere Therapeutics, Inc.TVTX

$2.74B+72.3%

Vera TherapeuticsVERA

$2.87B+87.5%

AnaptysBio, Inc.ANAB

$1.59B+180%

Cullinan Therapeutics, Inc.CGEM

$860.08M+94.2%

Viridian Therapeutics, Inc.VRDN

$2B+82.0%

Other financials

Income statement

See full

Operating income-$43.4M-85.8%

Net income-$40.4M-5.8%

EPS (diluted)-$0.57+95.3%

Balance sheet

See full

Cash & equivalents$55.1M+24.6%

Total debt$808.0K+159%

Total equity$296.5M+455%

Total assets$319.4M+312%

Cash flow

See full

Operating cash flow-$24.1M-28.4%

CapEx$3.0K—

Free cash flow-$33.7M—

Valuation

See full

Enterprise value$1.28B—

Returns & leverage

See full

Return on equity-132.5%+120pp

Debt / equity0×—

Current ratio14.3×-17.7×

Where this comes from

Computed from the period-end share price: $692.89M.

The official record: JBIO’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about JBIO's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is JBIO's market capitalization?: JBIO (JBIO) reported market capitalization of $692.89M in Q1 2026.
What does market capitalization mean?: The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.